Significance and Implications of Patient-reported Xerostomia in Sjögren's Syndrome: Findings From the National Institutes of Health Cohort

  title={Significance and Implications of Patient-reported Xerostomia in Sj{\"o}gren's Syndrome: Findings From the National Institutes of Health Cohort},
  author={Monisha Billings and Bruce A. Dye and Timothy J. Iafolla and Alan N. Baer and Margaret Grisius and Ilias Alevizos},
  pages={270 - 279}

Figures and Tables from this paper

Novel parotid sialo-cone-beam computerized tomography features in patients with suspected Sjogren's syndrome.
Sialo-CBCT demonstrates novel radiographic features which may clarify the diagnosis of SjS, and AECG-confirmed-SjS patients showed strong correlation with radiography features, whereas ACR 2012- confirmed-SJS patients did not.
Predictive value of ultrasound scoring in relation to clinical and histological parameters in xerostomia patients.
The results suggest that salivary gland tests including USS can aid in differentiating between SS and non-SS dry mouth, especially the subgroups of SS with lymphoma or at higher risk of developing lymphoma.
Hypocomplementemia in Primary Sjogren’s Syndrome: A Retrospective Study of 120 Treatment-Naive Chinese Patients
Objective To determine the prevalence of hypocomplementemia in primary Sjogren’s syndrome (pSS) patients and compare the clinical characteristics of patients with and without hypocomplementemia.
Comparative analysis of the 2016 ACR-EULAR and the 2002 AECG classification criteria for Sjögren's syndrome: Findings from the NIH cohort.
Findings from this cohort indicate that 2016 ACR-EULAR classification could be extended to classification of sSS, and there was high agreement between the two classification sets with comparable performance diagnostics.
Discrepancy between subjective symptoms, objective measures and disease activity indexes: the lesson of primary Sjögren's syndrome.
An overview of glandular dysfunction in pSS as well as the impact of discrepancy between objective assessment, subjective symptom and extraglandular disease activity on disease management are provided.
Ophthalmologic Manifestations of Primary Sjögren’s Syndrome
The unquestionable role of both the innate and adaptive immune system, participating actively in the induction and evolution of the disease, was recognized and the primary role of the inflammatory process was evidenced.
Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome.
The systemic phenotype of primary Sjögren's syndrome is strongly influenced by personal determinants such as age, gender, ethnicity and place of residence, which are key geoepidemiological players in driving the expression of systemic disease at diagnosis.
Characterization and Pathogenic Speculation of Xerostomia Associated with COVID-19: A Narrative Review
Results of the literature search indicated that xerostomia is one of prevalent and persistent oral symptoms associated with COVID-19, which is pathogenically related to viral cellular entry-relevant protein expression, renin-angiotensin system disturbance, salivary gland inflammation, cranial neuropathy, intercurrent taste dysfunction, comorbidities and medications.
Sjögren’s Syndrome as an Ocular Problem: Signs and Symptoms, Diagnosis, Treatment
  • D. Kopacz, P. Maciejewicz
  • Medicine
    Chronic Autoimmune Epithelitis - Sjogren's Syndrome and Other Autoimmune Diseases of the Exocrine Glands
  • 2019
Recent data on the ocular involvement and perspective of dry eye disease diagnosis and treatment in patients with Sjögren’s syndrome are presented.


Oral involvement in primary Sjögren syndrome.
Oral and dental disease in PSS is extensive and persistent and represents a significant burden of illness and early recognition of the significance of these findings by oral specialists could accelerate diagnosis and minimize oral morbidities.
Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants.
Distinguishing FLS from NS/SCS is essential in assessing LSG biopsies, before determining focus score, and a diagnosis of FLS with a focus score of ≥1 per 4 mm², is strongly associated with the ocular and serologic components of SS and reflects SS autoimmunity.
Classification criteria of Sjögren's syndrome.
Diagnostic value of labial minor salivary gland biopsy for Sjögren's syndrome: a systematic review.
Xerostomia: evaluation of a symptom with increasing significance.
Xerostomia is the subjective sensation of oral dryness. Although it is most commonly associated with salivary gland dysfunction, it may also occur with normal gland activity. Xerostomia may be an
Pathogenesis of Sjögren's syndrome
It is suggested that exocrine gland dysfunction may precede autoimmunity or represent a process independent from inflammation in the pathogenesis of Sjögren's syndrome.
Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sjögren's syndrome
Subjective swallowing difficulties were more common in pSS patients than in controls while objective signs of pharyngeal and oesophageal dysmotility were not and may be related to an impaired parasympathetic function.
Autonomic cardiovascular neuropathy in Sjögren's syndrome. A controlled study.
The results suggest that autonomic neuropathy is a feature of a significant portion of the SS population, and such patients should have appropriate evaluation and be investigated for evidence of SS.
Classification criteria for Sjögren's syndrome: we actually need to definitively resolve the long debate on the issue
To reach a consensus agreement on universally accepted classification criteria for SS seems to be a very desirable objective, despite the fact that two different criteria to classify patient with SS could be available.
Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations.
Disease manifestations in primary Sjogren's syndrome were associated with low sex hormone levels, dry mouth symptoms with low androgens, and dry eyes with low estrogens during DHEA therapy.